Stock A185490 EYEGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News EyeGene Inc.

Equities

A185490

KR7185490000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
2,820 KRW +0.53% Intraday chart for EyeGene Inc. +1.62% -33.88%
2023 EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd. CI
2023 EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
CI
EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
CI
EyeGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
EyeGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
CI
Maravai LifeSciences : Says Unit TriLink To Supply Proprietary Technology to EyeGene for Production of COVID-19 Vaccine
MT
EyeGene Inc.(KOSDAQ:A185490) added to S&P Global BMI Index
CI
EyeGene Inc. announced that it has received KRW 22 billion in funding from a group of investors
CI
EyeGene Inc. announced that it expects to receive KRW 22 billion in funding from a group of investors
CI
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
CI
EyeGene Inc. announced that it has received KRW 29.9998664 billion in funding from Meritz Securities Co., Ltd., Investment Arm, IBK Capital Corporation, Korea Investment & Securities Co., Ltd., Investment Arm
CI
EyeGene Inc. announced that it expects to receive KRW 29.9998664 billion in funding from a group of investors
CI
EyeGene Inc. announced that it has received KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
CI
EyeGene Inc. announced that it has received KRW 12.6 billion in funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc.
CI
EyeGene Inc. announced that it expects to receive funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc. and other investors
CI
EyeGene Inc. announced that it expects to receive KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
CI
EyeGene, Inc.(XKON:A185490) added to S&P Global BMI Index
CI
EyeGene, Inc. completed the sale of ICM co., Ltd.
CI
EyeGene, Inc. agreed to sell ICM co., Ltd for KRW 90 million.
CI
LB Investment Inc. through its fund LB Gemini New Growth Fund 16 acquired an unknown stake in EyeGene, Inc. from KoFC-Hanwha Pioneer Champ 2010 Fund 14 and 09-4 Hanwha Venture Investment Partnership, funds of Hanwha Investment Corp for KRW 1.7 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A185490 Stock
  4. News EyeGene Inc.